Colorectal Cancer Clinical Trials in Chicago

Showing 221-240 of 266 trials

Optimizing Navigation to Successful Colorectal Cancer Screening

NCT02192034

Colorectal cancer is the second leading cause of death from cancer in the United States. Two major barriers to successful colorectal cancer screening are appointment keeping and proper bowel preparation. The purpose of this study is to test the efficacy of a patient navigation program to increase colorectal cancer screening at Rush University Medical Center. The investigators hypothesize that colorectal cancer screening will be improved for subjects who utilize a patient navigator.

Colorectal Cancer Screening

Rush University Medical Center156 participantsStarted Mar 2013

Chicago, Illinois, United States

COMPLETEDPhase 1/22.2 miles

Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer

NCT00522665

The addition of RAD001, an mTOR inhibitor, to irinotecan and anti-EGFR antibody cetuximab may increase efficacy for patients with metastatic colorectal cancer who progressed on prior chemotherapy. This approach is biologically directed to overall target the cancer cell at multiple levels, and potentially preventing chemotherapy and EGFR-therapy resistance.

Colorectal Cancer

Hoosier Cancer Research Network41 participantsStarted Aug 2007

Chicago, Illinois, United States • Galesburg, Illinois, United States • Bloomington, Indiana, United States +11 more locations

Optimizing Navigation to Successful Colorectal Cancer Screening

Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Low Literacy Intervention for Colorectal Cancer Screening

Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Dignity Therapy in mCRC to Increase Peaceful Awareness & Impact Goals of Care Decision-Making

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Study of In-home Tests for Colorectal Cancer

FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors

An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer

Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer

Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer

Other Conditions in Chicago